bpc-157 lyme disease Facts and Statistics BPC 157.Peptide
Description
Clean the mouthpiece at least once a week with a dry cloth, as directed
This research profile is typical for peptides in the regenerative category and distinguishes BPC-157 from compounds like GLP-1 agonists (semaglutide, tirzepatide) that have progressed through human clinical trials and regulatory approval
Stopping because symptoms improved at week 2 means abandoning the protocol before the structural repair phase has completed
That decline correlates with reduced skin repair capacity, but the correlation does not prove that topical supplementation reverses the deficit
